Advanced Search
Contact | Corporate | Help

Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery

Sponsors:
  • University of California, San Francisco
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Esophageal Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: erlotinib
  • Drug: 5-fluorouracil
  • Drug: leucovorin
  • Drug: oxaliplatin
Enrollment:
25

Additional information about NCT00539617.


SourceSolution © 2008-2012